Improvement of clinical outcomes and liver function in cirrhotic patients by selective COX-2 inhibitors: A retrospective study
Saved in:
| Main Authors: | Zhu Yang, Ming Chen, Yang Tai, Huan Tong, Zhiyin Huang, Jinhang Gao, Chengwei Tang, Yuanyuan Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2024-12-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003364 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Causal associations of immunophenotypes with metabolic dysfunction-associated fatty liver disease and mediating pathways: a Mendelian randomization study
by: Kexin Xie, et al.
Published: (2024-12-01) -
COX-2 Inhibitors and Gastric Cancer
by: Zhen Wang, et al.
Published: (2014-01-01) -
Association between proton pump inhibitors and dementia risk: a Mendelian randomization study
by: Kexin Xie, et al.
Published: (2024-11-01) -
Hyperthyroidism with Biventricular Heart Failure and Cirrhotic Transformation of the Liver
by: Rashmi Dhital, et al.
Published: (2018-01-01) -
Seizure following the Use of the COX-2 Inhibitor Etoricoxib
by: Valentina Arnao, et al.
Published: (2017-01-01)